the positive rate in the control group was 10.3 % , while it was 10.7 % in the mild dysplasia group , 17.5 % in the moderate dysplasia group , 25.5 % in the severe dysplasia group , 31.3 % in the carcinoma in situ ( cis ) group and 41.4 % in the cervical cancer group .
C0334048
severe
C0007099
in